- doi:10.1371/journal.pone.0009019. PMC 2814854. PMID 20126400.
Luethi D,
Kolaczynska KE,
Walter M,
Suzuki M, Rice KC,
Blough BE,
Hoener MC,
Baumann MH, Liechti...
- 3412–3425. doi:10.1111/bph.13128. PMC 4500375. PMID 25765500.
Luethi D,
Kolaczynska KE,
Walter M,
Suzuki M, Rice KC,
Blough BE, et al. (July 2019). "Metabolites...
- Talanta. 179: 546–553. doi:10.1016/j.talanta.2017.11.020. PMID 29310273.
Kolaczynska K,
Thomann J,
Hoener M,
Liechti M (2021). "The
Pharmacological Profile...
-
Aspects (2 ed.). London: King's College. ISBN 978-0-12-800212-4.
Luethi D,
Kolaczynska KE,
Docci L, Krähenbühl S,
Hoener MC,
Liechti ME (May 2018). "Pharmacological...
- 12 (2): 215–233. doi:10.2217/pgs.10.171. PMID 21332315.
Thomann J,
Kolaczynska KE,
Stoeckmann OV,
Rudin D,
Vizeli P,
Hoener MC, et al. (2024). "In vitro...
-
stimulating effects. In contrast, SCs show
negligible activity towards TAAR1 (
Kolaczynska et al., 2021;
Rickli et al., 2015;
Simmler et al., 2014, 2016). [...]...
- ). Berkeley, CA:
Transform Press. ISBN 9780963009609. OCLC 25627628.
Kolaczynska KE,
Luethi D,
Trachsel D,
Hoener MC,
Liechti ME (2021). "Receptor Interaction...
- and Signaling. 1 (5): 559–579. doi:10.1002/wmts.42. ISSN 2190-460X.
Kolaczynska KE,
Luethi D,
Trachsel D,
Hoener MC,
Liechti ME (2019). "Receptor Interaction...
-
stimulating effects. In contrast, SCs show
negligible activity towards TAAR1 (
Kolaczynska et al., 2021;
Rickli et al., 2015;
Simmler et al., 2014, 2016). [...]...
-
representing an
interesting field for ****ure investigations.
Rickli A,
Kolaczynska K,
Hoener MC,
Liechti ME (May 2019). "Pharmacological characterization...
